Search Results - "Hellard, Prof Margaret"

Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study by Scott, Dr Nick, Palmer, Ms Anna, Tidhar, Mr Tom, Stoove, Prof Mark, Sacks-Davis, Dr Rachel, Doyle, A/Prof Joseph S., Pedrana, Dr Alisa, Thompson, Prof Alexander J., Wilson, Prof David P., Hellard, Prof Margaret

“…Hepatitis C elimination may be possible with broad uptake of direct-acting antiviral treatments (DAAs). In 2016 the Australian government committed A$1.2…”
Get full text

Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees by Dolan, Kate, Prof, Wirtz, Andrea L, PhD, Moazen, Babak, MScIH, Ndeffo-mbah, Martial, PhD, Galvani, Alison, Prof, Kinner, Stuart A, Prof, Courtney, Ryan, PhD, McKee, Martin, Prof, Amon, Joseph J, PhD, Maher, Lisa, Prof, Hellard, Margaret, Prof, Beyrer, Chris, Prof, Altice, Fredrick L, Prof

“…Summary The prison setting presents not only challenges, but also opportunities, for the prevention and treatment of HIV, viral hepatitis, and tuberculosis. We…”
Get full text

Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine by Grebely, Jason, Dr, Prins, Maria, Prof, Hellard, Margaret, Prof, Cox, Andrea L, Prof, Osburn, William O, PhD, Lauer, Georg, MD, Page, Kimberly, PhD, Lloyd, Andrew R, Prof, Dore, Gregory J, Prof

“…Summary Hepatitis C virus (HCV) was discovered more than two decades ago, but progress towards a vaccine has been slow. HCV infection will spontaneously clear…”
Get full text